Elevation of CSF tumor necrosis factor α levels in new daily persistent headache and treatment refractory chronic migraine

Todd Rozen, Sahar Z. Swidan

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Objective. - To determine if patients with new daily persistent headache (NDPH) have elevated levels of tumor necrosis factor α (TNF α) in the CSF. Background. - NDPH is considered one of the most treatment resistant of all headache syndromes. This reflects a lack of understanding of its pathogenesis. As a certain percentage of NDPH patients have their headaches start after an infection, the possibility of a persistent state of systemic or CNS inflammation comes into question. TNF α is a proinflammatory cytokine involved in brain immune and inflammatory activities, as well as in pain initiation. The goal of this study was to look at TNF α levels in the CSF of NDPH patients, to determine if CNS inflammation may play some role in the pathogenesis of this condition. Methods. - CSF TNF α levels were studied in 38 patients: 20 with NDPH and a control population of 16 patients with chronic migraine (CM), and 2 with post-traumatic headache (PT). Results. - CSF TNF α levels were elevated in 19 of 20 NDPH patients, 16 of 16 CM patients, and both PT patients. Serum TNF α levels were normal in most of the study subjects. Conclusion. - An elevation of CSF TNF α levels was found in almost all NDPH patients and suggest a role for TNF α in the pathogenesis of this condition. Surprisingly, all CM and PT patients tested had elevated CSF TNF α levels. In most patients with elevated CSF levels, serum TNF α levels were normal. All of these syndromes may be manifestations of CNS inflammation. As most of the positive-tested patients showed minimal to no improvement during aggressive inpatient treatment, persistent elevation of CSF TNF α levels may be one of the causes of treatment refractory CDH.

Original languageEnglish (US)
Pages (from-to)1050-1055
Number of pages6
JournalHeadache
Volume47
Issue number7
DOIs
StatePublished - Jul 1 2007
Externally publishedYes

Fingerprint

Migraine Disorders
Headache
Tumor Necrosis Factor-alpha
Post-Traumatic Headache
Therapeutics
Inflammation
Headache Disorders
Serum
Inpatients
Cytokines
Pain

Keywords

  • Cerebrospinal fluid
  • Chronic daily headache
  • Chronic migraine
  • New daily persistent headache
  • Tumor necrosis factor α

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Elevation of CSF tumor necrosis factor α levels in new daily persistent headache and treatment refractory chronic migraine. / Rozen, Todd; Swidan, Sahar Z.

In: Headache, Vol. 47, No. 7, 01.07.2007, p. 1050-1055.

Research output: Contribution to journalArticle

@article{4e29e34aabb54ee0aaee56309d96ac74,
title = "Elevation of CSF tumor necrosis factor α levels in new daily persistent headache and treatment refractory chronic migraine",
abstract = "Objective. - To determine if patients with new daily persistent headache (NDPH) have elevated levels of tumor necrosis factor α (TNF α) in the CSF. Background. - NDPH is considered one of the most treatment resistant of all headache syndromes. This reflects a lack of understanding of its pathogenesis. As a certain percentage of NDPH patients have their headaches start after an infection, the possibility of a persistent state of systemic or CNS inflammation comes into question. TNF α is a proinflammatory cytokine involved in brain immune and inflammatory activities, as well as in pain initiation. The goal of this study was to look at TNF α levels in the CSF of NDPH patients, to determine if CNS inflammation may play some role in the pathogenesis of this condition. Methods. - CSF TNF α levels were studied in 38 patients: 20 with NDPH and a control population of 16 patients with chronic migraine (CM), and 2 with post-traumatic headache (PT). Results. - CSF TNF α levels were elevated in 19 of 20 NDPH patients, 16 of 16 CM patients, and both PT patients. Serum TNF α levels were normal in most of the study subjects. Conclusion. - An elevation of CSF TNF α levels was found in almost all NDPH patients and suggest a role for TNF α in the pathogenesis of this condition. Surprisingly, all CM and PT patients tested had elevated CSF TNF α levels. In most patients with elevated CSF levels, serum TNF α levels were normal. All of these syndromes may be manifestations of CNS inflammation. As most of the positive-tested patients showed minimal to no improvement during aggressive inpatient treatment, persistent elevation of CSF TNF α levels may be one of the causes of treatment refractory CDH.",
keywords = "Cerebrospinal fluid, Chronic daily headache, Chronic migraine, New daily persistent headache, Tumor necrosis factor α",
author = "Todd Rozen and Swidan, {Sahar Z.}",
year = "2007",
month = "7",
day = "1",
doi = "10.1111/j.1526-4610.2006.00722.x",
language = "English (US)",
volume = "47",
pages = "1050--1055",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Elevation of CSF tumor necrosis factor α levels in new daily persistent headache and treatment refractory chronic migraine

AU - Rozen, Todd

AU - Swidan, Sahar Z.

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Objective. - To determine if patients with new daily persistent headache (NDPH) have elevated levels of tumor necrosis factor α (TNF α) in the CSF. Background. - NDPH is considered one of the most treatment resistant of all headache syndromes. This reflects a lack of understanding of its pathogenesis. As a certain percentage of NDPH patients have their headaches start after an infection, the possibility of a persistent state of systemic or CNS inflammation comes into question. TNF α is a proinflammatory cytokine involved in brain immune and inflammatory activities, as well as in pain initiation. The goal of this study was to look at TNF α levels in the CSF of NDPH patients, to determine if CNS inflammation may play some role in the pathogenesis of this condition. Methods. - CSF TNF α levels were studied in 38 patients: 20 with NDPH and a control population of 16 patients with chronic migraine (CM), and 2 with post-traumatic headache (PT). Results. - CSF TNF α levels were elevated in 19 of 20 NDPH patients, 16 of 16 CM patients, and both PT patients. Serum TNF α levels were normal in most of the study subjects. Conclusion. - An elevation of CSF TNF α levels was found in almost all NDPH patients and suggest a role for TNF α in the pathogenesis of this condition. Surprisingly, all CM and PT patients tested had elevated CSF TNF α levels. In most patients with elevated CSF levels, serum TNF α levels were normal. All of these syndromes may be manifestations of CNS inflammation. As most of the positive-tested patients showed minimal to no improvement during aggressive inpatient treatment, persistent elevation of CSF TNF α levels may be one of the causes of treatment refractory CDH.

AB - Objective. - To determine if patients with new daily persistent headache (NDPH) have elevated levels of tumor necrosis factor α (TNF α) in the CSF. Background. - NDPH is considered one of the most treatment resistant of all headache syndromes. This reflects a lack of understanding of its pathogenesis. As a certain percentage of NDPH patients have their headaches start after an infection, the possibility of a persistent state of systemic or CNS inflammation comes into question. TNF α is a proinflammatory cytokine involved in brain immune and inflammatory activities, as well as in pain initiation. The goal of this study was to look at TNF α levels in the CSF of NDPH patients, to determine if CNS inflammation may play some role in the pathogenesis of this condition. Methods. - CSF TNF α levels were studied in 38 patients: 20 with NDPH and a control population of 16 patients with chronic migraine (CM), and 2 with post-traumatic headache (PT). Results. - CSF TNF α levels were elevated in 19 of 20 NDPH patients, 16 of 16 CM patients, and both PT patients. Serum TNF α levels were normal in most of the study subjects. Conclusion. - An elevation of CSF TNF α levels was found in almost all NDPH patients and suggest a role for TNF α in the pathogenesis of this condition. Surprisingly, all CM and PT patients tested had elevated CSF TNF α levels. In most patients with elevated CSF levels, serum TNF α levels were normal. All of these syndromes may be manifestations of CNS inflammation. As most of the positive-tested patients showed minimal to no improvement during aggressive inpatient treatment, persistent elevation of CSF TNF α levels may be one of the causes of treatment refractory CDH.

KW - Cerebrospinal fluid

KW - Chronic daily headache

KW - Chronic migraine

KW - New daily persistent headache

KW - Tumor necrosis factor α

UR - http://www.scopus.com/inward/record.url?scp=34447322551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447322551&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4610.2006.00722.x

DO - 10.1111/j.1526-4610.2006.00722.x

M3 - Article

C2 - 17635596

AN - SCOPUS:34447322551

VL - 47

SP - 1050

EP - 1055

JO - Headache

JF - Headache

SN - 0017-8748

IS - 7

ER -